ANN SURG ONCOL 润色咨询

ANNALS OF SURGICAL ONCOLOGY

出版年份:1994 年文章数:9919 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:6.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向:肿瘤学;外科<br>经验分享:第二次投稿到接收50天左右,感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬,我目前已缴费,已让所有作者提交了披露声明,一周了,还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101138, encodeId=c7e021011388d, content=9月28日投稿,11月15号直接接收,无任何审稿意见,这是什么情况,难道是水刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e3559690, createdName=xiaoyudong222, createdTime=Thu Nov 17 16:34:53 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:12.16号投稿,投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向:prostate cancer<br>经验分享:请教一下各位:投稿后第二个EO已经under review 1个月了,还是没有到外审,要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100200, encodeId=87312100200ef, content=请问大家这个杂志发邮件说同意接受后多久会发会收到Springer发来的proof呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cc92469102, createdName=1243339am95暂无昵称, createdTime=Sun Nov 13 00:10:39 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;胸外科<br>经验分享:很快,审稿人意见很专业,一审1个月多一点,大修,两个审稿人提了10条意见,返修后二审20天,accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172697, encodeId=80cb21e2697fa, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:请问接收后一般多长时间收到proof啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91428253180, createdName=ms2000001206129608, createdTime=Sun Dec 03 14:34:30 CST 2023, time=2023-12-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147145, encodeId=3e62214e145d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审了两个月,拒稿,有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a65484149, createdName=ms1000001181498946, createdTime=Sun Jul 09 18:19:45 CST 2023, time=2023-07-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明(Disclosure form),但是为啥还是显示Awaiting disclosure form,有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2024-01-23 新来的小李 来自云南省

    偏重的研究方向:肿瘤学;外科
    经验分享:第二次投稿到接收50天左右,感觉很不错

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向:肿瘤学;外科<br>经验分享:第二次投稿到接收50天左右,感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬,我目前已缴费,已让所有作者提交了披露声明,一周了,还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101138, encodeId=c7e021011388d, content=9月28日投稿,11月15号直接接收,无任何审稿意见,这是什么情况,难道是水刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e3559690, createdName=xiaoyudong222, createdTime=Thu Nov 17 16:34:53 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:12.16号投稿,投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向:prostate cancer<br>经验分享:请教一下各位:投稿后第二个EO已经under review 1个月了,还是没有到外审,要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100200, encodeId=87312100200ef, content=请问大家这个杂志发邮件说同意接受后多久会发会收到Springer发来的proof呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cc92469102, createdName=1243339am95暂无昵称, createdTime=Sun Nov 13 00:10:39 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;胸外科<br>经验分享:很快,审稿人意见很专业,一审1个月多一点,大修,两个审稿人提了10条意见,返修后二审20天,accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172697, encodeId=80cb21e2697fa, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:请问接收后一般多长时间收到proof啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91428253180, createdName=ms2000001206129608, createdTime=Sun Dec 03 14:34:30 CST 2023, time=2023-12-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147145, encodeId=3e62214e145d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审了两个月,拒稿,有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a65484149, createdName=ms1000001181498946, createdTime=Sun Jul 09 18:19:45 CST 2023, time=2023-07-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明(Disclosure form),但是为啥还是显示Awaiting disclosure form,有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2022-10-11 0春夏秋冬0

    想请教一下投过稿的大佬,我目前已缴费,已让所有作者提交了披露声明,一周了,还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊,谢谢!

    7

    展开7条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向:肿瘤学;外科<br>经验分享:第二次投稿到接收50天左右,感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬,我目前已缴费,已让所有作者提交了披露声明,一周了,还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101138, encodeId=c7e021011388d, content=9月28日投稿,11月15号直接接收,无任何审稿意见,这是什么情况,难道是水刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e3559690, createdName=xiaoyudong222, createdTime=Thu Nov 17 16:34:53 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:12.16号投稿,投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向:prostate cancer<br>经验分享:请教一下各位:投稿后第二个EO已经under review 1个月了,还是没有到外审,要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100200, encodeId=87312100200ef, content=请问大家这个杂志发邮件说同意接受后多久会发会收到Springer发来的proof呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cc92469102, createdName=1243339am95暂无昵称, createdTime=Sun Nov 13 00:10:39 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;胸外科<br>经验分享:很快,审稿人意见很专业,一审1个月多一点,大修,两个审稿人提了10条意见,返修后二审20天,accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172697, encodeId=80cb21e2697fa, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:请问接收后一般多长时间收到proof啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91428253180, createdName=ms2000001206129608, createdTime=Sun Dec 03 14:34:30 CST 2023, time=2023-12-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147145, encodeId=3e62214e145d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审了两个月,拒稿,有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a65484149, createdName=ms1000001181498946, createdTime=Sun Jul 09 18:19:45 CST 2023, time=2023-07-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明(Disclosure form),但是为啥还是显示Awaiting disclosure form,有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2022-11-17 xiaoyudong222

    9月28日投稿,11月15号直接接收,无任何审稿意见,这是什么情况,难道是水刊吗

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向:肿瘤学;外科<br>经验分享:第二次投稿到接收50天左右,感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬,我目前已缴费,已让所有作者提交了披露声明,一周了,还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101138, encodeId=c7e021011388d, content=9月28日投稿,11月15号直接接收,无任何审稿意见,这是什么情况,难道是水刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e3559690, createdName=xiaoyudong222, createdTime=Thu Nov 17 16:34:53 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:12.16号投稿,投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向:prostate cancer<br>经验分享:请教一下各位:投稿后第二个EO已经under review 1个月了,还是没有到外审,要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100200, encodeId=87312100200ef, content=请问大家这个杂志发邮件说同意接受后多久会发会收到Springer发来的proof呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cc92469102, createdName=1243339am95暂无昵称, createdTime=Sun Nov 13 00:10:39 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;胸外科<br>经验分享:很快,审稿人意见很专业,一审1个月多一点,大修,两个审稿人提了10条意见,返修后二审20天,accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172697, encodeId=80cb21e2697fa, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:请问接收后一般多长时间收到proof啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91428253180, createdName=ms2000001206129608, createdTime=Sun Dec 03 14:34:30 CST 2023, time=2023-12-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147145, encodeId=3e62214e145d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审了两个月,拒稿,有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a65484149, createdName=ms1000001181498946, createdTime=Sun Jul 09 18:19:45 CST 2023, time=2023-07-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明(Disclosure form),但是为啥还是显示Awaiting disclosure form,有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2020-01-19 wangzilk

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:12.16号投稿,投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油!

    6

    展开6条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向:肿瘤学;外科<br>经验分享:第二次投稿到接收50天左右,感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬,我目前已缴费,已让所有作者提交了披露声明,一周了,还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101138, encodeId=c7e021011388d, content=9月28日投稿,11月15号直接接收,无任何审稿意见,这是什么情况,难道是水刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e3559690, createdName=xiaoyudong222, createdTime=Thu Nov 17 16:34:53 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:12.16号投稿,投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向:prostate cancer<br>经验分享:请教一下各位:投稿后第二个EO已经under review 1个月了,还是没有到外审,要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100200, encodeId=87312100200ef, content=请问大家这个杂志发邮件说同意接受后多久会发会收到Springer发来的proof呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cc92469102, createdName=1243339am95暂无昵称, createdTime=Sun Nov 13 00:10:39 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;胸外科<br>经验分享:很快,审稿人意见很专业,一审1个月多一点,大修,两个审稿人提了10条意见,返修后二审20天,accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172697, encodeId=80cb21e2697fa, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:请问接收后一般多长时间收到proof啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91428253180, createdName=ms2000001206129608, createdTime=Sun Dec 03 14:34:30 CST 2023, time=2023-12-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147145, encodeId=3e62214e145d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审了两个月,拒稿,有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a65484149, createdName=ms1000001181498946, createdTime=Sun Jul 09 18:19:45 CST 2023, time=2023-07-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明(Disclosure form),但是为啥还是显示Awaiting disclosure form,有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2022-02-12 ms2000001633593819

    偏重的研究方向:prostate cancer
    经验分享:请教一下各位:投稿后第二个EO已经under review 1个月了,还是没有到外审,要发邮件给编辑咨询一下不

    7

    展开7条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向:肿瘤学;外科<br>经验分享:第二次投稿到接收50天左右,感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬,我目前已缴费,已让所有作者提交了披露声明,一周了,还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101138, encodeId=c7e021011388d, content=9月28日投稿,11月15号直接接收,无任何审稿意见,这是什么情况,难道是水刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e3559690, createdName=xiaoyudong222, createdTime=Thu Nov 17 16:34:53 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:12.16号投稿,投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向:prostate cancer<br>经验分享:请教一下各位:投稿后第二个EO已经under review 1个月了,还是没有到外审,要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100200, encodeId=87312100200ef, content=请问大家这个杂志发邮件说同意接受后多久会发会收到Springer发来的proof呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cc92469102, createdName=1243339am95暂无昵称, createdTime=Sun Nov 13 00:10:39 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;胸外科<br>经验分享:很快,审稿人意见很专业,一审1个月多一点,大修,两个审稿人提了10条意见,返修后二审20天,accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172697, encodeId=80cb21e2697fa, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:请问接收后一般多长时间收到proof啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91428253180, createdName=ms2000001206129608, createdTime=Sun Dec 03 14:34:30 CST 2023, time=2023-12-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147145, encodeId=3e62214e145d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审了两个月,拒稿,有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a65484149, createdName=ms1000001181498946, createdTime=Sun Jul 09 18:19:45 CST 2023, time=2023-07-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明(Disclosure form),但是为啥还是显示Awaiting disclosure form,有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2022-11-13 1243339am95暂无昵称

    请问大家这个杂志发邮件说同意接受后多久会发会收到Springer发来的proof呢

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向:肿瘤学;外科<br>经验分享:第二次投稿到接收50天左右,感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬,我目前已缴费,已让所有作者提交了披露声明,一周了,还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101138, encodeId=c7e021011388d, content=9月28日投稿,11月15号直接接收,无任何审稿意见,这是什么情况,难道是水刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e3559690, createdName=xiaoyudong222, createdTime=Thu Nov 17 16:34:53 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:12.16号投稿,投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向:prostate cancer<br>经验分享:请教一下各位:投稿后第二个EO已经under review 1个月了,还是没有到外审,要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100200, encodeId=87312100200ef, content=请问大家这个杂志发邮件说同意接受后多久会发会收到Springer发来的proof呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cc92469102, createdName=1243339am95暂无昵称, createdTime=Sun Nov 13 00:10:39 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;胸外科<br>经验分享:很快,审稿人意见很专业,一审1个月多一点,大修,两个审稿人提了10条意见,返修后二审20天,accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172697, encodeId=80cb21e2697fa, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:请问接收后一般多长时间收到proof啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91428253180, createdName=ms2000001206129608, createdTime=Sun Dec 03 14:34:30 CST 2023, time=2023-12-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147145, encodeId=3e62214e145d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审了两个月,拒稿,有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a65484149, createdName=ms1000001181498946, createdTime=Sun Jul 09 18:19:45 CST 2023, time=2023-07-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明(Disclosure form),但是为啥还是显示Awaiting disclosure form,有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2023-05-22 新来的小李 来自四川省

    审稿速度:1.0
    偏重的研究方向:肿瘤;胸外科
    经验分享:很快,审稿人意见很专业,一审1个月多一点,大修,两个审稿人提了10条意见,返修后二审20天,accept。

    7

    展开7条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向:肿瘤学;外科<br>经验分享:第二次投稿到接收50天左右,感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬,我目前已缴费,已让所有作者提交了披露声明,一周了,还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101138, encodeId=c7e021011388d, content=9月28日投稿,11月15号直接接收,无任何审稿意见,这是什么情况,难道是水刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e3559690, createdName=xiaoyudong222, createdTime=Thu Nov 17 16:34:53 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:12.16号投稿,投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向:prostate cancer<br>经验分享:请教一下各位:投稿后第二个EO已经under review 1个月了,还是没有到外审,要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100200, encodeId=87312100200ef, content=请问大家这个杂志发邮件说同意接受后多久会发会收到Springer发来的proof呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cc92469102, createdName=1243339am95暂无昵称, createdTime=Sun Nov 13 00:10:39 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;胸外科<br>经验分享:很快,审稿人意见很专业,一审1个月多一点,大修,两个审稿人提了10条意见,返修后二审20天,accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172697, encodeId=80cb21e2697fa, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:请问接收后一般多长时间收到proof啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91428253180, createdName=ms2000001206129608, createdTime=Sun Dec 03 14:34:30 CST 2023, time=2023-12-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147145, encodeId=3e62214e145d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审了两个月,拒稿,有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a65484149, createdName=ms1000001181498946, createdTime=Sun Jul 09 18:19:45 CST 2023, time=2023-07-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明(Disclosure form),但是为啥还是显示Awaiting disclosure form,有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2023-12-03 ms2000001206129608 来自山东省

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:请问接收后一般多长时间收到proof啊

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向:肿瘤学;外科<br>经验分享:第二次投稿到接收50天左右,感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬,我目前已缴费,已让所有作者提交了披露声明,一周了,还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101138, encodeId=c7e021011388d, content=9月28日投稿,11月15号直接接收,无任何审稿意见,这是什么情况,难道是水刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e3559690, createdName=xiaoyudong222, createdTime=Thu Nov 17 16:34:53 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:12.16号投稿,投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向:prostate cancer<br>经验分享:请教一下各位:投稿后第二个EO已经under review 1个月了,还是没有到外审,要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100200, encodeId=87312100200ef, content=请问大家这个杂志发邮件说同意接受后多久会发会收到Springer发来的proof呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cc92469102, createdName=1243339am95暂无昵称, createdTime=Sun Nov 13 00:10:39 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;胸外科<br>经验分享:很快,审稿人意见很专业,一审1个月多一点,大修,两个审稿人提了10条意见,返修后二审20天,accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172697, encodeId=80cb21e2697fa, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:请问接收后一般多长时间收到proof啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91428253180, createdName=ms2000001206129608, createdTime=Sun Dec 03 14:34:30 CST 2023, time=2023-12-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147145, encodeId=3e62214e145d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审了两个月,拒稿,有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a65484149, createdName=ms1000001181498946, createdTime=Sun Jul 09 18:19:45 CST 2023, time=2023-07-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明(Disclosure form),但是为啥还是显示Awaiting disclosure form,有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2023-07-09 ms1000001181498946 来自上海

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:审了两个月,拒稿,有点慢

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2183518, encodeId=a0cc2183518bb, content=偏重的研究方向:肿瘤学;外科<br>经验分享:第二次投稿到接收50天左右,感觉很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Tue Jan 23 22:10:34 CST 2024, time=2024-01-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2093202, encodeId=658320932027b, content=想请教一下投过稿的大佬,我目前已缴费,已让所有作者提交了披露声明,一周了,还是显示Awaiting Disclosure Form和Under Review。不知这是否正常啊,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba816497670, createdName=0春夏秋冬0, createdTime=Tue Oct 11 20:27:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101138, encodeId=c7e021011388d, content=9月28日投稿,11月15号直接接收,无任何审稿意见,这是什么情况,难道是水刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e3559690, createdName=xiaoyudong222, createdTime=Thu Nov 17 16:34:53 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583626, encodeId=24dc58362615, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:12.16号投稿,投完马上显示under review. 12.23号显示awaiting reviewer invitation,第二天又重新显示under review.说明送审了。20年1月14号收到邮件被拒绝了。大家加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/13/6e7e5d3195777dbcf8e11aacbdd7e50d.jpg, createdBy=95765246036, createdName=wangzilk, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192642, encodeId=75c31192642cb, content=偏重的研究方向:prostate cancer<br>经验分享:请教一下各位:投稿后第二个EO已经under review 1个月了,还是没有到外审,要发邮件给编辑咨询一下不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd75680225, createdName=ms2000001633593819, createdTime=Sat Feb 12 11:46:29 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100200, encodeId=87312100200ef, content=请问大家这个杂志发邮件说同意接受后多久会发会收到Springer发来的proof呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cc92469102, createdName=1243339am95暂无昵称, createdTime=Sun Nov 13 00:10:39 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138380, encodeId=f37c21383804e, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;胸外科<br>经验分享:很快,审稿人意见很专业,一审1个月多一点,大修,两个审稿人提了10条意见,返修后二审20天,accept。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Mon May 22 13:36:08 CST 2023, time=2023-05-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2172697, encodeId=80cb21e2697fa, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:请问接收后一般多长时间收到proof啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91428253180, createdName=ms2000001206129608, createdTime=Sun Dec 03 14:34:30 CST 2023, time=2023-12-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147145, encodeId=3e62214e145d9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:审了两个月,拒稿,有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36a65484149, createdName=ms1000001181498946, createdTime=Sun Jul 09 18:19:45 CST 2023, time=2023-07-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=967940, encodeId=963e96e9402c, content=所有作者都填写了披露声明(Disclosure form),但是为啥还是显示Awaiting disclosure form,有人遇到这种情况么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210525/73c4efcc9fbe422d877a2b64136bf995/ab15db5cf09a48229b1ad003591b983e.jpg, createdBy=582b5111643, createdName=14617db6m31暂无昵称, createdTime=Sun May 23 16:43:59 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2021-05-23 14617db6m31暂无昵称

    所有作者都填写了披露声明(Disclosure form),但是为啥还是显示Awaiting disclosure form,有人遇到这种情况么

    14

    展开14条回复
共204条页码: 1/21页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分